封面
市場調查報告書
商品編碼
1612849

全球數位病理市場:產業分析、規模、佔有率、成長、趨勢和預測(2024-2031)

Digital Pathology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: | 出版商: Persistence Market Research | 英文 177 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

重要見解

  • 數位病理市場規模(2024年):80.5億美元
  • 市場規模預測(2031年):172億美元
  • 全球市場成長率(2024-2031):複合年增長率13.5%

市場成長動力:

全球數位病理學市場由幾個關鍵因素推動,包括影像技術的進步、慢性病盛行率的增加以及遠距醫療和遠距診斷的日益普及。數位病理學解決方案提供更快、更準確、更有效率的診斷過程,使醫療保健提供者能夠改善患者的治療結果。數位病理系統中人工智慧和機器學習 (ML) 的整合提高了診斷準確性和工作流程效率。此外,對數位醫療技術的投資增加以及對改善醫療基礎設施的需求也正在推動市場成長。

市場阻礙因素:

雖然數位病理市場正處於穩定成長的軌道上,但它也面臨著初始設備成本高、與現有醫療系統整合的複雜性以及對資料隱私和安全性的擔憂等課題。數位病理學解決方案在發展中地區的實施也因先進醫療技術的獲取有限和缺乏熟練的專業人員而受到阻礙。為了在全球市場上充分發揮數位病理解決方案的潛力,需要解決這些障礙。

市場機會:

技術進步、醫療保健支出增加以及個人化醫療的擴張為該市場帶來了巨大的成長機會。基於雲端的平台、人工智慧驅動的診斷以及診斷成像技術的改進的整合都指向了新的成長途徑。此外,對分子診斷、藥物開發和研究應用的需求不斷增長也為數位病理解決方案創造了巨大的商機。主要參與者、研究機構和醫療保健提供者之間的合作在推動數位病理技術的採用方面也發揮關鍵作用。

本報告調查了全球數位病理市場,並提供市場定義和概述、市場促進和阻礙因素、各種趨勢、市場機會、課題、市場規模(數量和部分數量)趨勢和預測,我們按不同類別/地區編製了詳細分析/主要國家、競爭環境、主要企業概況等

目錄

第1章執行摘要

第2章 市場概況

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 任務
    • 主要趨勢
  • 宏觀經濟因素
    • 世界產業展望
    • 世界GDP成長展望
  • COVID-19 影響分析
  • 預測因素:相關性和影響

第3章增值見解

  • 產品採用分析
  • 監管狀況
  • 價值鏈分析
  • 主要交易及合併
  • PESTLE分析
  • 波特五力分析
  • 母公司市場分析

第4章價格走勢分析

  • 主要亮點
  • 影響產品價格的主要因素
  • 價格分析(按類型)
  • 區域定價和產品偏好

第5章全球數位病理市場展望:趨勢與預測

  • 主要亮點
    • 市場規模預測
    • 市場規模/年成長率
    • 獲利機會
  • 市場規模分析與預測
  • 全球數位病理市場展望:按產品
    • 市場規模趨勢
    • 市場規模預測
    • 市場吸引力分析:產品
  • 全球數位病理市場展望:按應用分類
    • 市場規模趨勢
    • 市場規模預測
    • 市場吸引力分析:產品
  • 全球數位病理學市場展望:按最終用戶分類
    • 市場規模趨勢
    • 市場規模預測
    • 市場吸引力分析:產品

第6章全球數位病理市場展望:按地區

  • 主要亮點
  • 市場規模趨勢
  • 市場規模預測
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東/非洲
  • 市場吸引力分析:區域

第7章北美數位病理市場展望:趨勢與預測

  • 主要亮點
  • 價格分析
  • 市場規模趨勢
    • 按國家
    • 按產品
    • 按用途
    • 按最終用戶
  • 市場規模分析/預測:按國家劃分
    • 美國
    • 加拿大
  • 市場規模分析與預測:依產品分類
    • 數位病理設備
    • 數位病理軟體
  • 市場規模分析與預測:依應用分類
    • 臨床病理學
    • 分子診斷
    • 基礎研究/應用研究
    • 藥物開發
    • 其他
  • 市場規模分析/預測:按最終用戶
    • 醫院
    • 診斷實驗室
    • 製藥和生物技術公司
    • 法醫研究所
    • 研究機構
    • 合約研究組織
    • 診所
  • 市場吸引力分析

第8章歐洲數位病理市場展望:趨勢與預測

  • 主要亮點
  • 價格分析
  • 市場規模趨勢
  • 市場規模分析/預測:按國家劃分
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 土耳其
    • 其他
  • 市場規模分析與預測:依產品分類
  • 市場規模分析與預測:依應用分類
  • 市場規模分析/預測:按最終用戶
  • 市場吸引力分析

第9章東亞數位病理市場展望:趨勢與預測

  • 主要亮點
  • 價格分析
  • 市場規模趨勢
  • 市場規模分析/預測:按國家劃分
    • 中國
    • 日本
    • 韓國
  • 市場規模分析與預測:依產品分類
  • 市場規模分析與預測:依應用分類
  • 市場規模分析/預測:按最終用戶
  • 市場吸引力分析

第10章南亞與大洋洲數位病理市場展望:趨勢與預測

  • 主要亮點
  • 價格分析
  • 市場規模趨勢
  • 市場規模分析/預測:按國家劃分
    • 印度
    • 東南亞
    • 澳洲
    • 其他
  • 市場規模分析與預測:依產品分類
  • 市場規模分析與預測:依應用分類
  • 市場規模分析/預測:按最終用戶
  • 市場吸引力分析

第11章拉丁美洲數位病理市場展望:趨勢與預測

  • 主要亮點
  • 價格分析
  • 市場規模趨勢
  • 市場規模分析/預測:按國家劃分
    • 巴西
    • 墨西哥
    • 其他
  • 市場規模分析與預測:依產品分類
  • 市場規模分析與預測:依應用分類
  • 市場規模分析/預測:按最終用戶
  • 市場吸引力分析

第12章中東與非洲數位病理市場展望:趨勢與預測

  • 主要亮點
  • 價格分析
  • 市場規模趨勢
  • 市場規模分析/預測:按國家劃分
    • 海灣合作委員會國家
    • 埃及
    • 南非
    • 北非
    • 其他
  • 市場規模分析與預測:依產品分類
  • 市場規模分析與預測:依應用分類
  • 市場規模分析/預測:按最終用戶
  • 市場吸引力分析

第13章 競爭格局

  • 市場佔有率分析
  • 市場結構
  • 公司簡介(詳細資料:概述、財務狀況、策略、最新發展)
    • Leica Biosystems (Danaher Corporation)
    • F. Hoffmann-La Roche AG
    • Huron Technologies International Inc.
    • Koninklijke Philips N.V.
    • Olympus Corporation
    • Hamamatsu Photonics K.K.
    • Carl Zeiss AG
    • Nikon Corporation
    • 3DHISTECH Ltd.
    • Hologic Inc.
    • PerkinElmer, Inc.
    • Visiopharm
    • OptraSCAN, Inc.
    • Inspirata, Inc.

第14章附錄

簡介目錄
Product Code: PMRREP33922

Persistence Market Research has recently released a comprehensive report on the global Digital Pathology Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Digital Pathology Market Size (2024E): USD 8.05 Bn
  • Projected Market Value (2031F): USD 17.2 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 13.5%

Digital Pathology Market - Report Scope:

Digital pathology refers to the acquisition, management, sharing, and interpretation of pathology information in a digital environment. The market includes various products and services, such as digital pathology equipment, software, and services, that enable the transformation of traditional microscopy and pathology workflows. The growing adoption of digital pathology solutions is driven by factors such as the increasing demand for accurate diagnostics, advancements in telepathology, and the need for efficient and scalable pathology systems in clinical, research, and pharmaceutical settings.

Market Growth Drivers:

The global digital pathology market is driven by several key factors, including advancements in imaging technology, the increasing prevalence of chronic diseases, and the growing adoption of telemedicine and remote diagnostics. Digital pathology solutions provide faster, more accurate, and more efficient diagnostic processes, enabling healthcare providers to improve patient outcomes. The integration of artificial intelligence (AI) and machine learning (ML) in digital pathology systems is enhancing diagnostic accuracy and workflow efficiency. Additionally, increasing investments in digital health technologies and the demand for improved healthcare infrastructure are fueling market growth.

Market Restraints:

Despite its promising growth, the digital pathology market faces challenges such as high initial investment costs for equipment, integration complexities with existing healthcare systems, and concerns about data privacy and security. Additionally, the adoption of digital pathology solutions in developing regions is hindered by limited access to advanced healthcare technologies and a lack of skilled professionals. These barriers need to be addressed to unlock the full potential of digital pathology solutions in global markets.

Market Opportunities:

The market presents significant growth opportunities driven by advancements in technology, increased healthcare spending, and the expansion of personalized medicine. The integration of cloud-based platforms, AI-driven diagnostics, and improved imaging techniques offers new avenues for growth. Moreover, the rising demand for molecular diagnostics, drug development, and research applications presents substantial opportunities for digital pathology solutions. Collaborations between key market players, research institutes, and healthcare providers will play a crucial role in advancing the adoption of digital pathology technologies.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the digital pathology market?
  • Which types of digital pathology products are witnessing the highest adoption across different regions?
  • How is the integration of AI and machine learning transforming the digital pathology landscape?
  • Who are the leading players in the digital pathology market, and what strategies are they employing to remain competitive?
  • What are the emerging trends and future prospects in the digital pathology market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital pathology market, such as Danaher Corporation, F. Hoffmann-La Roche AG, and Koninklijke Philips N.V., are focusing on product innovation, strategic partnerships, and acquisitions to maintain their market leadership. These companies are investing heavily in research and development to create advanced digital pathology solutions that integrate AI, machine learning, and cloud technologies. Collaboration with healthcare providers, research institutes, and regulatory bodies is essential for market expansion and adoption. Furthermore, improving the interoperability of digital pathology systems with existing healthcare IT infrastructure is a key strategy for long-term growth.

Key Companies Profiled:

  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm

Digital Pathology Industry Research by Category:

By Product Type:

  • Digital Pathology Equipment
  • Digital Pathology Software
  • Digital Pathology Services

By Application:

  • Clinical Pathology
  • Molecular Diagnostics
  • Basic and Applied Research
  • Drug Development
  • Others

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Digital Pathology Market Snapshot, 2024 - 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Analysis
  • 3.7. Parent Market Analysis

4. Price Analysis, 2023A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 5.3. Global Digital Pathology Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019 - 2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
      • 5.3.3.1. Digital Pathology Equipment
        • 5.3.3.1.1. Whole Slide Scanners
        • 5.3.3.1.1.1. Brightfield Slide Scanners
        • 5.3.3.1.1.2. Fluorescence Slide Scanners
        • 5.3.3.1.1.3. Combination Slide Scanners
        • 5.3.3.1.2. Clinical Microscope
        • 5.3.3.1.3. Tissue Microarrays
      • 5.3.3.2. Digital Pathology Software
        • 5.3.3.2.1. Image Viewing and Analysis Software
        • 5.3.3.2.2. Digital Pathology Information Systems
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Digital Pathology Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
      • 5.4.3.1. Clinical Pathology
      • 5.4.3.2. Molecular Diagnostics
      • 5.4.3.3. Basic & Applied Research
      • 5.4.3.4. Drug Development
      • 5.4.3.5. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Digital Pathology Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Diagnostic Laboratories
      • 5.5.3.3. Pharmaceutical & Biotechnology Companies
      • 5.5.3.4. Forensic Laboratories
      • 5.5.3.5. Research Institutes
      • 5.5.3.6. Contract Research Organizations (CROs)
      • 5.5.3.7. Clinics
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Digital Pathology Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 7.4.1. Digital Pathology Equipment
      • 7.4.1.1. Whole Slide Scanners
        • 7.4.1.1.1. Brightfield Slide Scanners
        • 7.4.1.1.2. Fluorescence Slide Scanners
        • 7.4.1.1.3. Combination Slide Scanners
      • 7.4.1.2. Clinical Microscope
      • 7.4.1.3. Tissue Microarrays
    • 7.4.2. Digital Pathology Software
      • 7.4.2.1. Image Viewing and Analysis Software
      • 7.4.2.2. Digital Pathology Information Systems
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 7.5.1. Clinical Pathology
    • 7.5.2. Molecular Diagnostics
    • 7.5.3. Basic & Applied Research
    • 7.5.4. Drug Development
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic Laboratories
    • 7.6.3. Pharmaceutical & Biotechnology Companies
    • 7.6.4. Forensic Laboratories
    • 7.6.5. Research Institutes
    • 7.6.6. Contract Research Organizations (CROs)
    • 7.6.7. Clinics
  • 7.7. Market Attractiveness Analysis

8. Europe Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 8.4.1. Digital Pathology Equipment
      • 8.4.1.1. Whole Slide Scanners
        • 8.4.1.1.1. Brightfield Slide Scanners
        • 8.4.1.1.2. Fluorescence Slide Scanners
        • 8.4.1.1.3. Combination Slide Scanners
      • 8.4.1.2. Clinical Microscope
      • 8.4.1.3. Tissue Microarrays
    • 8.4.2. Digital Pathology Software
      • 8.4.2.1. Image Viewing and Analysis Software
      • 8.4.2.2. Digital Pathology Information Systems
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 8.5.1. Clinical Pathology
    • 8.5.2. Molecular Diagnostics
    • 8.5.3. Basic & Applied Research
    • 8.5.4. Drug Development
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic Laboratories
    • 8.6.3. Pharmaceutical & Biotechnology Companies
    • 8.6.4. Forensic Laboratories
    • 8.6.5. Research Institutes
    • 8.6.6. Contract Research Organizations (CROs)
    • 8.6.7. Clinics
  • 8.7. Market Attractiveness Analysis

9. East Asia Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 9.4.1. Digital Pathology Equipment
      • 9.4.1.1. Whole Slide Scanners
        • 9.4.1.1.1. Brightfield Slide Scanners
        • 9.4.1.1.2. Fluorescence Slide Scanners
        • 9.4.1.1.3. Combination Slide Scanners
      • 9.4.1.2. Clinical Microscope
      • 9.4.1.3. Tissue Microarrays
    • 9.4.2. Digital Pathology Software
      • 9.4.2.1. Image Viewing and Analysis Software
      • 9.4.2.2. Digital Pathology Information Systems
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 9.5.1. Clinical Pathology
    • 9.5.2. Molecular Diagnostics
    • 9.5.3. Basic & Applied Research
    • 9.5.4. Drug Development
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic Laboratories
    • 9.6.3. Pharmaceutical & Biotechnology Companies
    • 9.6.4. Forensic Laboratories
    • 9.6.5. Research Institutes
    • 9.6.6. Contract Research Organizations (CROs)
    • 9.6.7. Clinics
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 10.4.1. Digital Pathology Equipment
      • 10.4.1.1. Whole Slide Scanners
        • 10.4.1.1.1. Brightfield Slide Scanners
        • 10.4.1.1.2. Fluorescence Slide Scanners
        • 10.4.1.1.3. Combination Slide Scanners
      • 10.4.1.2. Clinical Microscope
      • 10.4.1.3. Tissue Microarrays
    • 10.4.2. Digital Pathology Software
      • 10.4.2.1. Image Viewing and Analysis Software
      • 10.4.2.2. Digital Pathology Information Systems
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 10.5.1. Clinical Pathology
    • 10.5.2. Molecular Diagnostics
    • 10.5.3. Basic & Applied Research
    • 10.5.4. Drug Development
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic Laboratories
    • 10.6.3. Pharmaceutical & Biotechnology Companies
    • 10.6.4. Forensic Laboratories
    • 10.6.5. Research Institutes
    • 10.6.6. Contract Research Organizations (CROs)
    • 10.6.7. Clinics
  • 10.7. Market Attractiveness Analysis

11. Latin America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 11.4.1. Digital Pathology Equipment
      • 11.4.1.1. Whole Slide Scanners
        • 11.4.1.1.1. Brightfield Slide Scanners
        • 11.4.1.1.2. Fluorescence Slide Scanners
        • 11.4.1.1.3. Combination Slide Scanners
      • 11.4.1.2. Clinical Microscope
      • 11.4.1.3. Tissue Microarrays
    • 11.4.2. Digital Pathology Software
      • 11.4.2.1. Image Viewing and Analysis Software
      • 11.4.2.2. Digital Pathology Information Systems
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 11.5.1. Clinical Pathology
    • 11.5.2. Molecular Diagnostics
    • 11.5.3. Basic & Applied Research
    • 11.5.4. Drug Development
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic Laboratories
    • 11.6.3. Pharmaceutical & Biotechnology Companies
    • 11.6.4. Forensic Laboratories
    • 11.6.5. Research Institutes
    • 11.6.6. Contract Research Organizations (CROs)
    • 11.6.7. Clinics
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 12.4.1. Digital Pathology Equipment
      • 12.4.1.1. Whole Slide Scanners
        • 12.4.1.1.1. Brightfield Slide Scanners
        • 12.4.1.1.2. Fluorescence Slide Scanners
        • 12.4.1.1.3. Combination Slide Scanners
      • 12.4.1.2. Clinical Microscope
      • 12.4.1.3. Tissue Microarrays
    • 12.4.2. Digital Pathology Software
      • 12.4.2.1. Image Viewing and Analysis Software
      • 12.4.2.2. Digital Pathology Information Systems
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 12.5.1. Clinical Pathology
    • 12.5.2. Molecular Diagnostics
    • 12.5.3. Basic & Applied Research
    • 12.5.4. Drug Development
    • 12.5.5. Others
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostic Laboratories
    • 12.6.3. Pharmaceutical & Biotechnology Companies
    • 12.6.4. Forensic Laboratories
    • 12.6.5. Research Institutes
    • 12.6.6. Contract Research Organizations (CROs)
    • 12.6.7. Clinics
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Leica Biosystems (Danaher Corporation)
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. F. Hoffmann-La Roche AG
    • 13.3.3. Huron Technologies International Inc.
    • 13.3.4. Koninklijke Philips N.V.
    • 13.3.5. Olympus Corporation
    • 13.3.6. Hamamatsu Photonics K.K.
    • 13.3.7. Carl Zeiss AG
    • 13.3.8. Nikon Corporation
    • 13.3.9. 3DHISTECH Ltd.
    • 13.3.10. Hologic Inc.
    • 13.3.11. PerkinElmer, Inc.
    • 13.3.12. Visiopharm
    • 13.3.13. OptraSCAN, Inc.
    • 13.3.14. Inspirata, Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations